Eric J. Brown

Also affiliated with Philadelphia University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models”.

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Nature Communications(2020)10.1038/s41467-020-17127-2

N/A

0DataRank · unranked

372 citations

Haineng Xu, Erin George, Dorothy Hallberg, Sushil Kumar, Veena Jagannathan +16 more

CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100394

N/A

0DataRank · unranked

91 citations

Erin George, Yasuto Kinose, Hyoung Kim, Jennifer Shah, Jasmine D. Peake +16 more

C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2444

N/A

0DataRank · unranked

79 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more

A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1079

N/A

0DataRank · unranked

34 citations

Margaret Whicker, Gareth Davies, Sushil Kumar, Krista Kinneer, Haineng Xu +13 more

Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer

Research Square(2023)10.21203/rs.3.rs-3314138/v1

N/A

0DataRank · unranked

2 citations

Yasuto Kinose, Haineng Xu, Hyoung Kim, Sushil Kumar, Xiaoyin Shan +19 more

Improved detection of DNA replication fork-associated proteins

Cell Reports(2024)10.1016/j.celrep.2024.114178

N/A

0DataRank · unranked

13 citations

Ya‐Chu Chang, Ryan L. Ragland, Yee Mon Thu, Muzaffer Ahmad Kassab, Rahul Shubhra Mandal +12 more

RNA 2'-O-methylation promotes persistent R-loop formation and AID-mediated IgH class switch recombination

BMC Biology(2024)10.1186/s12915-024-01947-5

N/A

0DataRank · unranked

3 citations

Yibin Chen, Xin Wang, Bo He, Eric J. Brown, Xiaochun Yu +1 more

The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models

Contributions to music education(2024)10.20517/cdr.2024.53

N/A

0DataRank · unranked

0 citations

Patrick L. Garcia, Rebecca B. Vance, Eric O. Heard, Eric J. Brown, Karina J. Yoon +1 more

Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.31.621311

N/A

0DataRank · unranked

0 citations

Lovely Raghav, Dominick J. Rich, Travis P. Schrank, Joseph A. Califano, John N. Lukens +17 more

Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf053

N/A

0DataRank · unranked

2 citations

Lovely Raghav, Dominick J. Rich, Travis P. Schrank, Joseph A. Califano, John N. Lukens +17 more

Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

10.1158/1078-0432.23814207.v1

N/A

0DataRank · unranked

0 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more